Laden...
No images? Click here Tuesday, 14 June 2022 MEDIA ADVISORY Vaccines and immunization for monkeypox: Interim guidance, 14 June 2022On 14 June, WHO published a new vaccine and immunization guidance for monkeypox: https://www.who.int/publications/i/item/who-mpx-immunization-2022.1This interim guidance provides the first WHO recommendations on use of (smallpox) vaccines for monkeypox. The goal of the global outbreak response for monkeypox is to control the outbreak, and to effectively use public health measures to prevent onward spread of the disease. Judicious use of vaccines can support this response.Based on currently assessed risks and benefits and regardless of vaccine supply, mass vaccination is not required nor recommended for monkeypox at this time. All decisions around immunization with smallpox or monkeypox vaccines should be by shared clinical decision-making, based on a joint assessment of risks and benefits, between a health care provider and prospective vaccinee, on a case-by-case basis. Control of monkeypox outbreaks primarily relies on public health measures including surveillance, contact-tracing, isolation and care of patients. While smallpox vaccines are expected to provide some protection against monkeypox, clinical data are limited. The supply of vaccines is limited and access strategies are under discussion. WHO is working closely with Member States and partners to define what type of coordination mechanism could be put in place to ensure fair access to vaccines (and treatments)All efforts should be made to administer vaccines for monkeypox within a framework of collaborative research and randomized clinical trial (RCT) protocols with standardized data collection tools for clinical and outcome data.Further guidance on Monkeypox Clinical management and infection prevention and control for monkeypox: Interim rapid response guidance, 10 June 2022Interim advice on Risk Communication and Community Engagement during the monkeypox outbreak in Europe, (2022)Minimum data set case reporting formSurveillance, case investigation and contact tracing for Monkeypox (includes contact tracing)Laboratory guidance for national laboratoriesInterim guidance on surveillance, case investigation and contact tracing for monkeypoxPublic health advice for MSMLatest Disease Outbreak NewsPlease see the Monkeypox photo gallery below. Please note that the media should register via the below link by clicking on "media registration". Media contacts: You are receiving this NO-REPLY email because you are included on a WHO mail list.
|
Laden...
Laden...